Core Viewpoint - The Hong Kong technology sector is experiencing a strong rally, driven by multiple favorable factors including increased expectations for Federal Reserve interest rate cuts and improved market liquidity, alongside significant revenue growth in Alibaba's cloud business and a resurgence in AI focus [1]. Group 1: Market Performance - As of November 27, 2025, the CSI Hong Kong Stock Connect Technology Index (931573) has seen a strong increase, with notable gains in constituent stocks such as Huahong Semiconductor (up 5.36%), Kangfang Biotech (up 4.89%), and Li Auto (up 3.87%) [1]. - The Hong Kong Technology ETF (159751) has risen by 0.73%, marking its fourth consecutive increase, with the latest price reported at 1.1 HKD [1]. Group 2: Influencing Factors - The recent rally in the Hong Kong technology sector is attributed to the anticipated easing of monetary policy by the Federal Reserve, which is expected to enhance liquidity in the market [1]. - The combination of the Federal Reserve's halt on balance sheet reduction and the relaxation of SLR regulations is expected to limit liquidity pressure in the medium term [1]. Group 3: Index Composition - The CSI Hong Kong Stock Connect Technology Index comprises 50 large-cap technology companies with high R&D investment and revenue growth, reflecting the overall performance of leading technology stocks within the Hong Kong Stock Connect [1]. - As of October 31, 2025, the top ten weighted stocks in the index include Alibaba-W, Tencent Holdings, and SMIC, collectively accounting for 66.81% of the index [2].

Core Viewpoint - WuXi Biologics (02269) announced the issuance of 4.01 million shares due to the exercise of options on November 26, 2025 [1] Summary by Relevant Categories - **Company Actions** - WuXi Biologics will issue 4.01 million shares as a result of option exercises [1]

Core Viewpoint - WuXi Biologics (02269) announced the issuance of 4.01 million shares due to the exercise of options on November 26, 2025 [1] Summary by Relevant Sections - Company Actions - WuXi Biologics will issue 4.01 million shares as a result of option exercises [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： WuXi Biologics (Cayman) Inc. 藥明生物技術有限公司*（於開曼群島註冊成立的有限公司）*僅供識別 呈交日期： 2025年11月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) 02269 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | ...

Group 1 - The Hang Seng Index has risen by 1.15%, with the Hang Seng Tech sector leading the gains, followed by healthcare, internet, and consumer sectors, while banks are relatively weak [1] - The consumer sector opened high and has maintained a strong position, currently up by 1.88%. Notable stocks include Xiaomi Group up by 5.33%, Baidu Group up by 3.94%, and Kuaishou up by 3.5%, with several others like Alibaba, SMIC, and BYD also showing gains around 2% [3] - The healthcare sector has also seen significant gains, currently up by 1.95%. Key performers include Kangfang Biotech up by 4.98%, CSPC Pharmaceutical up by 4.37%, and China Biologic Products up by 3.79% [3] Group 2 - The banking sector experienced a sharp decline at the open but has since rebounded slightly, currently up by 0.42%. Notable increases include Citic Bank up by 2.34%, with nearly ten other banks like Qingdao Bank and Agricultural Bank also rising over 1% [3] - Some banks, such as Zhengzhou Bank and Everbright Bank, are experiencing slight declines despite the overall sector rebound [3]

Group 1 - The core viewpoint of the news highlights a positive market sentiment driven by favorable factors such as the Federal Reserve's dovish stance and a call between the US and Chinese leaders, leading to a collective rise in major indices [1] - The AI industry chain is a focal point, with hardware sectors like Google's OCS concept and Meta's potential multi-billion dollar procurement of Google's TPU driving significant gains in related stocks [1] - The application side sees a shift in sentiment with Singapore's AISG moving away from Meta towards Alibaba's Qianwen, further boosting AI applications and leading to new highs in core stocks, which also positively impacts gaming stocks [1] Group 2 - Dongwu Securities notes a reduction in short-term risk factors for the Hong Kong stock market, suggesting that the current position is attractive for medium to long-term investment [2] - The expectation of a potential interest rate cut by the Federal Reserve in December could support a rebound in the Hong Kong market [2] - The upcoming Central Economic Work Conference in December may refocus market attention on policy, which has not yet been fully priced in [3] - The narrative around the AI technology bubble in the US has weakened, leading to a significant pullback in Hong Kong tech stocks, which now present an attractive investment opportunity [4] Group 3 - The Hong Kong Technology ETF closely tracks the CSI Hong Kong Stock Connect Technology Index, which selects 50 large-cap, high R&D investment, and high revenue growth tech companies to reflect the overall performance of tech leaders in the Hong Kong Stock Connect [5] - As of October 31, 2025, the top ten weighted stocks in the CSI Hong Kong Stock Connect Technology Index account for 66.81% of the index, including major players like Alibaba, Tencent, and BYD [5]

Core Insights - The top three companies by Hong Kong Stock Connect shareholding ratios are China Telecom (72.65%), Da Zhong Gong Yong (70.66%), and Green Power Environmental (69.50%) [1][2] - Alibaba-W, Xiaomi Group-W, and Tencent Holdings saw the largest increases in shareholding amounts over the last five trading days, with increases of 4.412 billion, 3.153 billion, and 1.752 billion respectively [1][2] - WuXi Biologics, Crystal International, and Ganfeng Lithium experienced the largest decreases in shareholding amounts over the last five trading days, with decreases of 547 million, 503 million, and 300 million respectively [1][3] Shareholding Ratios - The latest shareholding ratios for the top 20 companies in Hong Kong Stock Connect are led by: - China Telecom (100.83 billion shares, 72.65%) - Da Zhong Gong Yong (3.77 billion shares, 70.66%) - Green Power Environmental (2.81 billion shares, 69.50%) [2] Recent Increases in Shareholding - The top 10 companies with the largest increases in shareholding over the last five trading days include: - Alibaba-W: +4.412 billion (27.96 million shares) - Xiaomi Group-W: +3.153 billion (78.16 million shares) - Tencent Holdings: +1.752 billion (2.80 million shares) [2] Recent Decreases in Shareholding - The top 10 companies with the largest decreases in shareholding over the last five trading days include: - WuXi Biologics: -547 million (17.18 million shares) - Crystal International: -503 million (49.52 million shares) - Ganfeng Lithium: -300 million (6.04 million shares) [3]

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 6.05 million ordinary shares on November 25, 2025, as part of the stock option plan adopted prior to its initial public offering on January 5, 2016, which was revised on August 10, 2016 [1] Group 1 - The company is exercising options under its pre-IPO stock option plan [1] - A total of 6.05 million ordinary shares will be issued [1] - The announcement is part of the company's ongoing equity management strategy [1]

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 6.05 million ordinary shares on November 25, 2025, as part of its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1] Group 1 - The company will issue 6.05 million ordinary shares [1]

| 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | | 02269 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | 於下列日期開始時的結存(註1) | | 2025年11月19日 | | 4,107,272,633 | | 0 | | 4,107,272,633 | | 1). 就根據股份計劃授予參與人（發行人的董事除外）的股份獎勵或期權 | | | | 4,000 | 0.0001 % | HKD | 1.67 ...